Overview
Rong Niu practices in Changzhou, China. Niu is rated as a Distinguished expert by MediFind in the treatment of Lung Adenocarcinoma. Their top areas of expertise are Lung Adenocarcinoma, Lung Cancer, EGFR Positive Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC).
Their clinical research consists of co-authoring 36 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 16 articles in the study of Lung Adenocarcinoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung AdenocarcinomaNiu isDistinguished. Learn about Lung Adenocarcinoma.
- Experienced
- Adult Soft Tissue SarcomaNiu isExperienced. Learn about Adult Soft Tissue Sarcoma.
- EGFR Positive Lung CancerNiu isExperienced. Learn about EGFR Positive Lung Cancer.
- Lung CancerNiu isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Squamous Cell Lung Carcinoma
- Stomach CancerNiu isExperienced. Learn about Stomach Cancer.